<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0190">
 <label>38</label>
 <element-citation publication-type="journal" id="sbref0190">
  <person-group person-group-type="author">
   <name>
    <surname>Chong</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Xue</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Xiong</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Cong</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>A lipopeptide HIV-1/2 fusion inhibitor with highly potent in vitro, ex vivo, and in vivo antiviral activity</article-title>
  <source>J. Virol.</source>
  <volume>91</volume>
  <issue>11</issue>
  <year>2017</year>
 </element-citation>
</ref>
